1,276
Views
70
CrossRef citations to date
0
Altmetric
Research Paper

MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines

, , , , &
Pages 419-427 | Received 09 Oct 2013, Accepted 22 Dec 2013, Published online: 21 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ali Afgar, Pezhman Fard-Esfahani, Amirhosein Mehrtash, Kayhan Azadmanesh, Farnaz Khodarahmi, Mahdis Ghadir & Ladan Teimoori-Toolabi. (2016) MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition. Cancer Biology & Therapy 17:11, pages 1126-1138.
Read now
Dhirendra Kumar Singh, Sudeep Bose & Sachin Kumar. (2016) Regulation of expression of microRNAs by DNA methylation in lung cancer. Biomarkers 21:7, pages 589-599.
Read now
Zheng Zhou, Yanhe Su & Xianen Fa. (2015) Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b. OncoTargets and Therapy 8, pages 3603-3612.
Read now

Articles from other publishers (67)

Shu Zhou, Hailong Ou, Yatao Wu, Dan Qi, Xiaming Pei, Xiaohui Yu, Xiaoxiao Hu & Erxi Wu. (2023) Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy. Pharmacology & Therapeutics, pages 108434.
Crossref
Bo Bin Lee, Dongho Kim, Yujin Kim, Joungho Han, Young Mog Shim & Duk-Hwan Kim. (2023) Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells. Clinical Epigenetics 15:1.
Crossref
Syed Tasleem Raza, Saliha Rizvi, Sheeba Afreen, Sanchita Srivastava, Zainab Siddiqui, Naseem Fatima, Zeba Siddiqi & Farzana Mahdi. (2023) Association of the circulating micro-RNAs with susceptible and newly diagnosed type 2 diabetes mellitus cases. Advances in Biomarker Sciences and Technology 5, pages 57-67.
Crossref
Afsane Bahrami & Gordon A. Ferns. (2022) Diagnostic, Prognostic, and Therapeutic Value of miR-148b in Human Cancers. Current Molecular Medicine 22:10, pages 860-869.
Crossref
Elnaz Ghoreishi, Seyedeh Zahra Shahrokhi, Faranak Kazerouni & Ali Rahimipour. (2022) Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches. BMC Endocrine Disorders 22:1.
Crossref
Nick A. Alden, Julien H. Arrizabalaga, Yiming Liu, Shantu Amin, Krishne Gowda, Shun Yao, Marco Archetti, Adam B. Glick & Daniel J. Hayes. (2022) Delivery of Therapeutic miR-148b Mimic via Poly(β Amino Ester) Polyplexes for Post-transcriptional Gene Regulation and Apoptosis of A549 Cells. Langmuir 38:32, pages 9833-9843.
Crossref
Aritania Sousa Santos, Ludmila Rodrigues Pinto Ferreira, Amanda Cabral da Silva, Laís Isidoro Alves, Jullian Gabriel Damasceno, Leslie Kulikowski, Edecio Cunha-Neto & Maria Elizabeth Rossi da Silva. (2022) Progression of Type 1 Diabetes: Circulating MicroRNA Expression Profiles Changes from Preclinical to Overt Disease. Journal of Immunology Research 2022, pages 1-15.
Crossref
Ancuta Jurj, Oana Zanoaga, Cornelia Braicu & Ioana Berindan-Neagoe. 2022. MicroRNA. MicroRNA 153 167 .
Najmeh Dorraki, Zari Naderi Ghale-Noie, Nooshin Sadegh Ahmadi, Vahideh Keyvani, Rosita Azar Bahadori, Arash Salmani Nejad, Michael Aschner, Hossein Pourghadamyari, Samaneh Mollazadeh & Hamed Mirzaei. (2021) miRNA-148b and its role in various cancers. Epigenomics 13:24, pages 1939-1960.
Crossref
Muhammad Adnan, Azhar Rasul, Ghulam Hussain, Muhammad Ajmal Shah, Iqra Sarfraz, Bushra Nageen, Ammara Riaz, Rida Khalid, Muhammad Asrar, Zeliha Selamoglu, Şevki Adem & Satyajit D. Sarker. (2021) Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities. Current Drug Targets 22:5, pages 488-504.
Crossref
Maria Mortoglou, David Wallace, Aleksandra Buha Djordjevic, Vladimir Djordjevic, E. Damla Arisan & Pinar Uysal-Onganer. (2021) MicroRNA-Regulated Signaling Pathways: Potential Biomarkers for Pancreatic Ductal Adenocarcinoma. Stresses 1:1, pages 30-47.
Crossref
Samaneh Heydarzadeh, Maryam Ranjbar, Farokh Karimi, Farhad Seif & Mohammad Reza Alivand. (2021) Overview of host miRNA properties and their association with epigenetics, long non-coding RNAs, and Xeno-infectious factors. Cell & Bioscience 11:1.
Crossref
M. Tang, Q. Wang, K. Wang & F. Wang. (2020) Mesenchymal stem cells-originated exosomal microRNA-152 impairs proliferation, invasion and migration of thyroid carcinoma cells by interacting with DPP4. Journal of Endocrinological Investigation 43:12, pages 1787-1796.
Crossref
K. M. Taufiqul Arif, Esther K. Elliott, Larisa M. Haupt & Lyn R. Griffiths. (2020) Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets. Cancers 12:10, pages 2922.
Crossref
Yiming Liu, Jacob T. Bailey, Mohammad Abu-Laban, Shue Li, Cong Chen, Adam B. Glick & Daniel J. Hayes. (2020) Photocontrolled miR-148b nanoparticles cause apoptosis, inflammation and regression of Ras induced epidermal squamous cell carcinomas in mice. Biomaterials 256, pages 120212.
Crossref
Kah Keng Wong. (2020) DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications. Cellular Oncology 43:5, pages 779-792.
Crossref
Fatemeh Khatami, Bagher Larijani, Ramin Heshmat, Shirzad Nasiri, Mohammad Haddadi‐Aghdam, Ladan Teimoori‐Toolabi & Seyed M. Tavangar. (2020) Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF V600E mutation as biomarkers for papillary thyroid carcinoma . Journal of Cellular Physiology 235:10, pages 6954-6968.
Crossref
Anna Sadakierska-Chudy. (2020) MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics. Biomolecules 10:9, pages 1285.
Crossref
Xiaohui Wan, Dongrui Guo, Qi Zhu & Rongfeng Qu. (2020) microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3. American Journal of Physiology-Gastrointestinal and Liver Physiology 319:3, pages G309-G322.
Crossref
Ying‐Zhi Liang, Jia‐Jiang‐Hui Li, Huan‐Bo Xiao, Yan He, Ling Zhang & Yu‐Xiang Yan. (2018) Identification of stress‐related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta‐analysis. Journal of Diabetes 12:9, pages 633-644.
Crossref
Junhe Cui, Na Liu, Zhehan Chang, Yongsheng Gao, Mulan Bao, Yabin Xie, Wenqiang Xu, Xiaolei Liu, Shuyuan Jiang, You Liu, Rui Shi, Wei Xie, Xiaoe Jia, Jinghua Shi, Changhong Ren, Kerui Gong, Chunyang Zhang, Rengui Bade, Guo Shao & Xunming Ji. (2020) Exosomal MicroRNA-126 from RIPC Serum Is Involved in Hypoxia Tolerance in SH-SY5Y Cells by Downregulating DNMT3B. Molecular Therapy - Nucleic Acids 20, pages 649-660.
Crossref
Li-Na Yan, Xin Zhang, Fang Xu, Yuan-Yuan Fan, Biao Ge, Hui Guo & Zi-Ling Li. (2020) Four-microRNA signature for detection of type 2 diabetes. World Journal of Clinical Cases 8:10, pages 1923-1931.
Crossref
Yin Du, Xiaozhen Ma, Lei Ma, Siyuan Li, Juan Zheng, Junlin Lv, Long Cui & Jianrui Lv. (2020) Inhibition of microRNA‐148b‐3p alleviates oxygen‐glucose deprivation/reoxygenation‐induced apoptosis and oxidative stress in HT22 hippocampal neuron via reinforcing Sestrin2/Nrf2 signalling. Clinical and Experimental Pharmacology and Physiology 47:4, pages 561-570.
Crossref
Yiwei Guo, Wenxiang Wang, Yiqin Chen, Yan Sun, Yuchen Li, Fangyuan Guan, Qi Shen, Yiruo Guo & Wenchang Zhang. (2020) Continuous gibberellin A3 exposure from weaning to sexual maturity induces ovarian granulosa cell apoptosis by activating Fas-mediated death receptor signaling pathways and changing methylation patterns on caspase-3 gene promoters. Toxicology Letters 319, pages 175-186.
Crossref
Hyejeong Kim, Yeongrim Ko, Hyojin Park, Haiying Zhang, Yoonjeong Jeong, Yeomyeong Kim, Minyoung Noh, Songyi Park, Young-Myeong Kim & Young-Guen Kwon. (2019) MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells. Experimental & Molecular Medicine 51:11, pages 1-11.
Crossref
M. Perusina Lanfranca, J.K. Thompson, F. Bednar, C. Halbrook, C. Lyssiotis, B. Levi & T.L. Frankel. (2019) Metabolism and epigenetics of pancreatic cancer stem cells. Seminars in Cancer Biology 57, pages 19-26.
Crossref
Jialun Li, Ruiping Wang, Xueli Hu, Yingying Gao, Zhen Wang, Jiwen Li & Jiemin Wong. (2019) Activated MEK/ERK Pathway Drives Widespread and Coordinated Overexpression of UHRF1 and DNMT1 in Cancer cells. Scientific Reports 9:1.
Crossref
Haseeb Zubair, Shafquat Azim, Mohammad Aslam Khan, Girijesh Kumar Patel, Aamir Ahmad, Sachin Pai, Seema Singh & Ajay P. Singh. 2019. Epigenetics of Cancer Prevention. Epigenetics of Cancer Prevention 251 270 .
Marzieh Ghanbarian, Ali Afgar, Reza Yadegarazari, Rezvan Najafi & Ladan Teimoori-Toolabi. (2018) Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Biomedicine & Pharmacotherapy 108, pages 1070-1080.
Crossref
Duguang LiXiaowei QianPeng XuXiaodong WangZhennan LiJianjun QianJie Yao. (2018) Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing. DNA and Cell Biology 37:10, pages 839-849.
Crossref
Jiulin Chan, Xingxing Hu, Congcong Wang & Qianghua Xu. (2018) miRNA-152 targets GATA1 to regulate erythropoiesis in Chionodraco hamatus. Biochemical and Biophysical Research Communications 501:3, pages 711-717.
Crossref
Wenjun Lin, Lu Wang, Shengwu Yang, Xin Chen, Xiongbai Zhu & Piji Chen. (2018) Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma. Oncology Letters.
Crossref
Shitong Zhang, Jianjun Jin, Xiaoxiao Tian & Lijuan Wu. (2017) hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC. Oncotarget 8:61, pages 104508-104524.
Crossref
Yi-Yang Wen, Wei-Tao Liu, Hao-Ran Sun, Xin Ge, Zhu-Mei Shi, Min Wang, Wei Li, Jian-Ying Zhang, Ling-Zhi Liu & Bing-Hua Jiang. (2017) IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer. Scientific Reports 7:1.
Crossref
Azam Rajabpour, Ali Afgar, Habibollah Mahmoodzadeh, Jalal-e-Din Radfar, Farzad Rajaei & Ladan Teimoori-Toolabi. (2017) MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells. Cancer Chemotherapy and Pharmacology 80:4, pages 765-775.
Crossref
Victoria K. Xie, Zhiwei Li, Yongmin Yan, Zhiliang Jia, Xiangsheng Zuo, Zhenlin Ju, Jing Wang, Jiawei Du, Dacheng Xie, Keping Xie & Daoyan Wei. (2017) DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. Clinical Cancer Research 23:18, pages 5585-5597.
Crossref
Masoumeh Azizi, Pezhman Fard-Esfahani, Habibollah Mahmoodzadeh, Mohammad Sadegh Fazeli, Kayhan Azadmanesh, Sirous Zeinali & Ladan Teimoori-Toolabi. (2017) MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes . Epigenomics 9:8, pages 1059-1075.
Crossref
Ganji Purnachandra Nagaraju, Christina Wu, Neha Merchant, Zhengjia Chen, Gregory B. Lesinski & Bassel F. El-Rayes. (2017) Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer. Cancer Letters 402, pages 110-116.
Crossref
Azam Rajabpour, Farzad Rajaei & Ladan Teimoori-Toolabi. (2017) Molecular alterations contributing to pancreatic cancer chemoresistance. Pancreatology 17:2, pages 310-320.
Crossref
Lorne J. Hofseth, Ainsley Weston & Curtis C. Harris. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 25 .
Xia Chen, Hua Guo, Fuxia Li & Di Fan. (2017) Physcion 8-O-?-glucopyranoside suppresses the metastasis of breast cancer in vitro and in vivo by modulating DNMT1. Pharmacological Reports 69:1, pages 36-44.
Crossref
Laura Pazzaglia, Chiara Novello, Amalia Conti, Serena Pollino, Piero Picci & Maria Serena Benassi. (2016) miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma. Cellular Oncology 40:1, pages 77-88.
Crossref
Dieter H Heiland, Roberto Ferrarese, Rainer Claus, Fangping Dai, Anie P Masilamani, Eva Kling, Astrid Weyerbrock, Teresia Kling, Sven Nelander & Maria S Carro. (2016) c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas. Oncotarget 8:4, pages 6940-6954.
Crossref
Keiichi Yonemori, Hiroshi Kurahara, Kosei Maemura & Shoji Natsugoe. (2016) MicroRNA in pancreatic cancer. Journal of Human Genetics 62:1, pages 33-40.
Crossref
Yasan Sadeghian, Zahra Kamyabi-Moghaddam, Seyed Mohamad Hossein Tabatabaei Nodushan, Samaneh Khoshbakht, Behnam Pedram, Emad Yahaghi, Aram Mokarizadeh & Mahdi Mohebbi. (2015) RETRACTED ARTICLE: Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinoma. Tumor Biology 37:12, pages 16379-16380.
Crossref
Qiang Wang, Yong Wang, Yuqing Xing, Yi Yan, Peng Guo, Jianguang Zhuang, Fawei Qin & Jie Zhang. (2016) RETRACTED: Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells. Biomedicine & Pharmacotherapy 83, pages 372-380.
Crossref
Hailey B. Koh, Anne M. Scruggs & Steven K. Huang. (2016) Transforming Growth Factor-β1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts. Journal of Biological Chemistry 291:37, pages 19287-19298.
Crossref
V. Taucher, H. Mangge & J. Haybaeck. (2016) Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application. Cellular Oncology 39:4, pages 295-318.
Crossref
Ashujit Tagde, Hasan Rajabi, Dina Stroopinsky, Reddy Gali, Maroof Alam, Audrey Bouillez, Surender Kharbanda, Richard Stone, David Avigan & Donald Kufe. (2016) MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia. Oncotarget 7:26, pages 38974-38987.
Crossref
XUEXIANG LIU, JINWAN LI, FENGXIAN QIN & SHENGMING DAI. (2016) miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer. Oncology Letters 11:6, pages 3911-3916.
Crossref
Katayoun Ziari, Mojtaba Zarea, Masoumeh Gity, Amir Farshid Fayyaz, Emad Yahaghi, Ebrahim Khodaverdi Darian & Amir Masoud Hashemian. (2015) RETRACTED ARTICLE: Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker. Tumor Biology 37:5, pages 5765-5768.
Crossref
Zongmei MouXiangting XuMei DongJin Xu. (2016) MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent Manner. Medical Science Monitor 22, pages 2809-2815.
Crossref
Jingjing Wu, Shunyu Zhao, Qing Tang, Fang Zheng, YuQin Chen, LiJun Yang, Xiaobing Yang, Liuning Li, WanYin Wu & Swei Sunny Hann. (2015) Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Naeemeh Ghasemkhani, Sahar Shadvar, Yasamin Masoudi, Amir Jouya Talaei, Emad Yahaghi, Peyman Karimi Goudarzi & Ebrahim Shakiba. (2015) RETRACTED ARTICLE: Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Diagnostic Pathology 10:1.
Crossref
Chengguang Sui, Fandong Meng, Yan Li & Youhong Jiang. (2015) miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression. Journal of Translational Medicine 13:1.
Crossref
Cheng-gui Miao, Dan Qin, Chuan-lai Du, Hua Ye, Wei-jing Shi, You-yi Xiong, Xiao-lin Zhang, Hao Yu, Jin-feng Dou, Shi-tang Ma, Mei-song Qin, Han-zhen Liu, Yan-xi Fang, Guo-liang Zhou, Jian-zhong Chen, Xu He, Cheng Huang, Yan Huang, Bing Zhang, Tong-wen Song & Jun Li. (2015) DNMT1 activates the canonical Wnt signaling in rheumatoid arthritis model rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2. International Immunopharmacology 28:1, pages 344-353.
Crossref
Shuang Liang, Ming-Hui Zhao, Jeong-woo Choi, Nam-Hyung Kim & Xiang-Shun Cui. (2015) Scriptaid Treatment Decreases DNA Methyltransferase 1 Expression by Induction of MicroRNA-152 Expression in Porcine Somatic Cell Nuclear Transfer Embryos. PLOS ONE 10:8, pages e0134567.
Crossref
Y He, J R Chevillet, G Liu, T K Kim & K Wang. (2014) The effects of micro RNA on the absorption, distribution, metabolism and excretion of drugs . British Journal of Pharmacology 172:11, pages 2733-2747.
Crossref
Tian Yang, Asmitananda Thakur, Tianjun Chen, Li Yang, Gao Lei, Yiqian Liang, Shuo Zhang, Hui Ren & Mingwei Chen. (2015) MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer. Tumor Biology 36:6, pages 4357-4365.
Crossref
Nicola Amodio, Marco Rossi, Lavinia Raimondi, Maria Rita Pitari, Cirino Botta, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2015) miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 6:15, pages 12837-12861.
Crossref
Yinyi Yie, Shunyu Zhao, Qin Tang, Fang Zheng, Jingjing Wu, LiJuan Yang, ShiGuan Deng & Swei Sunny Hann. (2014) Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPK?-mediated reduction of DNA methyltransferase 1. Molecular and Cellular Biochemistry 402:1-2, pages 63-74.
Crossref
ShunYu Zhao, Jingjing Wu, Fang Zheng, Qing Tang, LiJun Yang, Liuning Li, WanYin Wu & Swei Sunny Hann. (2015) β‐elemene inhibited expression of DNA methyltransferase 1 through activation of ERK 1/2 and AMPK α signalling pathways in human lung cancer cells: the role of Sp1 . Journal of Cellular and Molecular Medicine 19:3, pages 630-641.
Crossref
Ammad A. Farooqi, Muhammad Z. Qureshi & Muhammad Ismail. 2015. Personalized Epigenetics. Personalized Epigenetics 461 474 .
Yan Song, Yuan Tian, Wei-liang Bai & Xiu-lan Ma. (2014) Expression and clinical significance of microRNA-152 in supragalottic laryngeal carcinoma. Tumor Biology 35:11, pages 11075-11079.
Crossref
Zhenshun Cheng, Rongli Ma, Weijun Tan & Li Zhang. (2014) MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2. Experimental & Molecular Medicine 46:9, pages e112-e112.
Crossref
Yi-Wu Dang, Jing Zeng, Rong-Quan He, Min-Hua Rong, Dian-Zhong Luo & Gang Chen. (2014) Effects of miR-152 on Cell Growth Inhibition, Motility Suppression and Apoptosis Induction in Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention 15:12, pages 4969-4976.
Crossref
Yunshu Su, Yuchang Wang, Hongmin Zhou, Lei Lei & Lijun Xu. (2014) MicroRNA‐152 targets ADAM17 to suppress NSCLC progression. FEBS Letters 588:10, pages 1983-1988.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.